Critical lessons from the ENHANCE trial

JAMA. 2008 Feb 27;299(8):953-5. doi: 10.1001/jama.299.8.953.
No abstract available

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Atherosclerosis / prevention & control*
  • Azetidines / therapeutic use
  • Carotid Arteries / diagnostic imaging*
  • Conflict of Interest
  • Data Interpretation, Statistical
  • Drug Approval*
  • Drug Industry*
  • Ezetimibe
  • Humans
  • Hyperlipoproteinemia Type II / drug therapy*
  • Mass Media*
  • Randomized Controlled Trials as Topic*
  • Simvastatin / therapeutic use
  • Ultrasonography

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Simvastatin
  • Ezetimibe